Description
Generic Version of Apalutamide Available in India?
Apalutamide is the generic name of the medication and is its international nonproprietary name. Apalutamide is marketed under the brand name Apatide among others.
Apalutamide shows a significant decrease in the risk of disease progression and reduces the risk of mortality in metastatic castration-sensitive prostate cancer patients. The drug promises quality of life as measured by the complete functional assessment of cancer therapy-prostate, offering radiographic progression-free survival in patients.
Apalutamide in combination with anti-androgen therapy will significantly improve chances for survival among mCSPC patients. On the other hand, Apalutamide plus androgen-deprivation therapy (ADT) shows a significant decrease in the risk of disease progression and reduces the risk of mortality by 35 per cent among nmCRPC patients.
Will this product be accessible across all regions of India?
The product -Apatide (Apalutamide) Tablet will be available across India on request. Apalutamide is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
NEWS / UPDATES
- BDR launches generic Apalutamide to treat prostate cancer.
- Lupin receives tentative approval from US FDA for apalutamide tablets.
- Recommendations of the SEC (Oncology &Haematology)made in its 160th meeting held on
30.10.2023 & 31.10.2023 at CDSCO (HQ), New Delhi: - Recommendations of the SEC (Oncology & Haematology) made in its 127th meeting held on
15.06.2022 at CDSCO (HQ), New Delhi: - Lupin Receives Tentative Approval from U.S. FDA for Apalutamide Tablets